Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

(MedPage Today) -- Two investigational anti-B7-H3 antibody-drug conjugates (ADCs) significantly improved survival outcomes in patients with relapsed small-cell lung cancer (SCLC), according to a pair of Chinese trials.
In the TAISHAN-302 study...